Moreover, IBD patients exhibited lower prevalence of nausea, vomiting, and diarrhea, but increased rates of constipation (11%) in comparison to the general population (103)
Weight Watchers gives you access to both: Med+ members who engaged regularly with the GLP-1 Success Program lost 29.1% more body weight , on average, in 12 months than those who did not engage in behavioral support.^ ^Based on an internal analysis of 3,325 members who requested at least 1 GLP-1 medication refill through Weight Watchers Med+ and self-reported both a starting weight and weight at week 52
Cell Cycle 13 , 19471955 (2014)
Primary benefits of retatrutide for non-diabetic weight loss include: Significant reduction in body weight Improved eating habits and control over cravings Increased energy for daily tasks and activities Enhanced self-confidence and mood Better participation in social activities involving food Smaller clothing sizes and improved mobility Lower risk of obesity-related complications A new option for patients who are refractory to other treatments
We have not made it a mandatory program
A study published by Mdecins Sans Frontires (MSF) and Yale School of Medicine in March 2024 highlighted the large mark-up on the price of GLP-1 drugs